Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer — Stella

Recruiting

Back to Breast Carcinoma trials

Trial locations(2 sites)

United States

Los Angeles General Medical Center, Los Angeles, California

USC / Norris Comprehensive Cancer Center, Los Angeles, California

Key details

Sponsor

University of Southern California

Collaborators

National Cancer Institute (NCI)

Enrollment target

~150 participants

Started

June 2025

Primary completion

June 2027

Age range

30 Years – 75 Years

Sex

Female only

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov